Four lessons from global health drug discovery: Medicine for an ailing industry?

Abstract

In recent years, the pharmaceutical industry has faced many challenges to its business model, undergoing tremendous change and turmoil to survive. Are there any lessons to be drawn from drug discovery focused on Global Health, where there is little market incentive? © 2012 American Chemical Society.